The following 7 images provide visual information about the product associated with Zejula NDC 0173-0909 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Molecular structure - zejula tab spl graphic 01
Figure 1. Progression-Free Survival in Patients with HR-Deficient Tumors (Intent-to-Treat Population, n = 373) - zejula tab spl graphic 02
Figure 2. Progression-Free Surivival in the Overall Population (Intent-to-Treat Population, n=733) - zejula tab spl graphic 03
Figure 3. Progression-Free Survival in the gBRCAmut Cohort Based on IRC Assessment (Intent-to-Treat Population, n = 203) - zejula tab spl graphic 04
Zejula 100 mg tablet 30 count label - zejula tab spl graphic 05
Zejula 200 mg tablet 30 count label - zejula tab spl graphic 06
Zejula 300 mg tablet 30 count label - zejula tab spl graphic 07